Related Experiment Video
Updated: Jul 5, 2026

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation
Published on: June 8, 2018
What Is the Role of Irreversible Electroporation for Pancreatic Cancer?
Robert C G Martin1, Christopher D Wilson1
1Division of Surgical Oncology, Hiram C Polk Department of Surgery, University of Louisville School of Medicine, 315 E. Broadway - M10 - Room#311, Louisville, KY 40202, USA.
Abstract:
Irreversible electroporation (IRE) has proven itself to be a viable surgical intervention for patients with borderline resectable pancreatic cancer and locally-advanced pancreatic cancer (LAPC). IRE has demonstrated encouraging survival and response outcomes when combined with induction chemotherapy versus patient populations that receive chemotherapy and/or chemo-radiation therapy alone. The optimal management of patients with LAPC is evolving quickly with the advent of improved IRE implementation. This article will present the current status of the role of IRE in patients with pancreatic cancer.
Related Concept Videos
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy

